AdaptHealth Corp. (NASDAQ: AHCO) Stock Competitors & Peer Comparison
See AHCO's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AHCO and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AHCO | $6.49 | +1.09% | 883M | 13.24 | $0.49 | N/A |
| ABT | $108.33 | -0.42% | 187.4B | 20.79 | $5.21 | +2.28% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $94.17 | +1.15% | 120.5B | 17.03 | $5.53 | +3.02% |
| SYK | $303.13 | -1.58% | 116.2B | 22.64 | $13.39 | +1.14% |
| BSX | $47.80 | +1.81% | 71.1B | 15.42 | $3.10 | N/A |
| EW | $89.90 | +0.13% | 51.8B | 33.29 | $2.70 | N/A |
| DXCM | $87.90 | -2.02% | 33.2B | 34.47 | $2.55 | N/A |
| GEHC | $68.86 | -1.23% | 31.1B | 15.10 | $4.56 | +0.20% |
| PHG | $25.89 | -0.61% | 25.3B | 14.79 | $1.75 | +3.82% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
AHCO vs ABT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, ABT has a market cap of 187.4B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while ABT trades at $108.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas ABT's P/E ratio is 20.79. In terms of profitability, AHCO's ROE is -0.15%, compared to ABT's ROE of +0.11%. Regarding short-term risk, AHCO is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
AHCO vs BSX-PA Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, AHCO's ROE is -0.15%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, AHCO is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BSX-PA's competition here
Medtronic plc (NYSE: MDT)
AHCO vs MDT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, MDT has a market cap of 120.5B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while MDT trades at $94.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas MDT's P/E ratio is 17.03. In terms of profitability, AHCO's ROE is -0.15%, compared to MDT's ROE of +0.11%. Regarding short-term risk, AHCO is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
AHCO vs SYK Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, SYK has a market cap of 116.2B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while SYK trades at $303.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas SYK's P/E ratio is 22.64. In terms of profitability, AHCO's ROE is -0.15%, compared to SYK's ROE of +0.16%. Regarding short-term risk, AHCO is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
AHCO vs BSX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, BSX has a market cap of 71.1B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while BSX trades at $47.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas BSX's P/E ratio is 15.42. In terms of profitability, AHCO's ROE is -0.15%, compared to BSX's ROE of +0.15%. Regarding short-term risk, AHCO is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
AHCO vs EW Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, EW has a market cap of 51.8B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while EW trades at $89.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas EW's P/E ratio is 33.29. In terms of profitability, AHCO's ROE is -0.15%, compared to EW's ROE of +0.10%. Regarding short-term risk, AHCO is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
AHCO vs DXCM Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, DXCM has a market cap of 33.2B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while DXCM trades at $87.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas DXCM's P/E ratio is 34.47. In terms of profitability, AHCO's ROE is -0.15%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, AHCO is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
AHCO vs GEHC Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, GEHC has a market cap of 31.1B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while GEHC trades at $68.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas GEHC's P/E ratio is 15.10. In terms of profitability, AHCO's ROE is -0.15%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, AHCO is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
AHCO vs PHG Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, PHG has a market cap of 25.3B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while PHG trades at $25.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas PHG's P/E ratio is 14.79. In terms of profitability, AHCO's ROE is -0.15%, compared to PHG's ROE of +0.10%. Regarding short-term risk, AHCO is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
AHCO vs ZBH Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, ZBH has a market cap of 19B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while ZBH trades at $98.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas ZBH's P/E ratio is 11.56. In terms of profitability, AHCO's ROE is -0.15%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, AHCO is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
AHCO vs ABMD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas ABMD's P/E ratio is 65.36. In terms of profitability, AHCO's ROE is -0.15%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, AHCO is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
AHCO vs PEN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, PEN has a market cap of 12.7B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while PEN trades at $322.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas PEN's P/E ratio is 84.16. In terms of profitability, AHCO's ROE is -0.15%, compared to PEN's ROE of +0.11%. Regarding short-term risk, AHCO is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
AHCO vs SWAV Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas SWAV's P/E ratio is 78.76. In terms of profitability, AHCO's ROE is -0.15%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, AHCO is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
AHCO vs SNN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, SNN has a market cap of 12.1B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while SNN trades at $28.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas SNN's P/E ratio is 13.58. In terms of profitability, AHCO's ROE is -0.15%, compared to SNN's ROE of +0.12%. Regarding short-term risk, AHCO is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
AHCO vs ALGN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, ALGN has a market cap of 11.4B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while ALGN trades at $158.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas ALGN's P/E ratio is 14.46. In terms of profitability, AHCO's ROE is -0.15%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, AHCO is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
AHCO vs GMED Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, GMED has a market cap of 10.6B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while GMED trades at $78.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas GMED's P/E ratio is 17.63. In terms of profitability, AHCO's ROE is -0.15%, compared to GMED's ROE of +0.12%. Regarding short-term risk, AHCO is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
AHCO vs GKOS Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, GKOS has a market cap of 10.5B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while GKOS trades at $177.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas GKOS's P/E ratio is -206.37. In terms of profitability, AHCO's ROE is -0.15%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, AHCO is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check GKOS's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
AHCO vs BIO-B Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, BIO-B has a market cap of 10.4B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while BIO-B trades at $381.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas BIO-B's P/E ratio is -67.15. In terms of profitability, AHCO's ROE is -0.15%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, AHCO is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
AHCO vs BIO Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, BIO has a market cap of 10.4B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while BIO trades at $386.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas BIO's P/E ratio is 41.65. In terms of profitability, AHCO's ROE is -0.15%, compared to BIO's ROE of +0.03%. Regarding short-term risk, AHCO is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BIO's competition here
Insulet Corp. (NASDAQ: PODD)
AHCO vs PODD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, PODD has a market cap of 10.2B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while PODD trades at $147.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas PODD's P/E ratio is 25.12. In terms of profitability, AHCO's ROE is -0.15%, compared to PODD's ROE of +0.27%. Regarding short-term risk, AHCO is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check PODD's competition here
Masimo Corporation (NASDAQ: MASI)
AHCO vs MASI Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas MASI's P/E ratio is 44.43. In terms of profitability, AHCO's ROE is -0.15%, compared to MASI's ROE of +0.09%. Regarding short-term risk, AHCO is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
AHCO vs BRKR Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, BRKR has a market cap of 8.9B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while BRKR trades at $58.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas BRKR's P/E ratio is 29.40. In terms of profitability, AHCO's ROE is -0.15%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, AHCO is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
AHCO vs BRKRP Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, BRKRP has a market cap of 8.6B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while BRKRP trades at $431.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas BRKRP's P/E ratio is 234.13. In terms of profitability, AHCO's ROE is -0.15%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, AHCO is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BRKRP's competition here
Inari Medical, Inc. (NASDAQ: NARI)
AHCO vs NARI Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas NARI's P/E ratio is -59.24. In terms of profitability, AHCO's ROE is -0.15%, compared to NARI's ROE of -0.00%. Regarding short-term risk, AHCO is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check NARI's competition here
Haemonetics Corporation (NYSE: HAE)
AHCO vs HAE Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, HAE has a market cap of 4.7B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while HAE trades at $102.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas HAE's P/E ratio is 20.54. In terms of profitability, AHCO's ROE is -0.15%, compared to HAE's ROE of +0.11%. Regarding short-term risk, AHCO is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check HAE's competition here
LivaNova PLC (NASDAQ: LIVN)
AHCO vs LIVN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, LIVN has a market cap of 4.5B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while LIVN trades at $81.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas LIVN's P/E ratio is 19.46. In terms of profitability, AHCO's ROE is -0.15%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, AHCO is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
AHCO vs ITGR Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while ITGR trades at $126.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas ITGR's P/E ratio is 19.76. In terms of profitability, AHCO's ROE is -0.15%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, AHCO is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
AHCO vs IRTC Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, IRTC has a market cap of 4.1B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while IRTC trades at $123.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas IRTC's P/E ratio is -287.05. In terms of profitability, AHCO's ROE is -0.15%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, AHCO is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
AHCO vs AXNX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas AXNX's P/E ratio is -709.80. In terms of profitability, AHCO's ROE is -0.15%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, AHCO is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
AHCO vs TMDX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while TMDX trades at $89.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas TMDX's P/E ratio is 45.68. In terms of profitability, AHCO's ROE is -0.15%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, AHCO is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
AHCO vs AXGN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, AXGN has a market cap of 2.6B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while AXGN trades at $48.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas AXGN's P/E ratio is 127.05. In terms of profitability, AHCO's ROE is -0.15%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, AHCO is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check AXGN's competition here
Neogen Corporation (NASDAQ: NEOG)
AHCO vs NEOG Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while NEOG trades at $11.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas NEOG's P/E ratio is 42.25. In terms of profitability, AHCO's ROE is -0.15%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, AHCO is more volatile compared to NEOG. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check NEOG's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
AHCO vs UFPT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, UFPT has a market cap of 2.2B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while UFPT trades at $288.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas UFPT's P/E ratio is 29.50. In terms of profitability, AHCO's ROE is -0.15%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, AHCO is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check UFPT's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
AHCO vs ESTA Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, ESTA has a market cap of 2.2B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while ESTA trades at $74.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas ESTA's P/E ratio is -58.96. In terms of profitability, AHCO's ROE is -0.15%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, AHCO is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
AHCO vs NVCR Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, NVCR has a market cap of 2.1B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while NVCR trades at $17.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas NVCR's P/E ratio is -13.80. In terms of profitability, AHCO's ROE is -0.15%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, AHCO is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check NVCR's competition here
NuVasive, Inc. (NASDAQ: NUVA)
AHCO vs NUVA Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas NUVA's P/E ratio is 75.00. In terms of profitability, AHCO's ROE is -0.15%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, AHCO is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check NUVA's competition here
Butterfly Network, Inc. (NYSE: BFLY)
AHCO vs BFLY Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, BFLY has a market cap of 2B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while BFLY trades at $7.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas BFLY's P/E ratio is -30.67. In terms of profitability, AHCO's ROE is -0.15%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, AHCO is more volatile compared to BFLY. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BFLY's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
AHCO vs INSP Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, INSP has a market cap of 1.8B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while INSP trades at $63.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas INSP's P/E ratio is 27.76. In terms of profitability, AHCO's ROE is -0.15%, compared to INSP's ROE of +0.18%. Regarding short-term risk, AHCO is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check INSP's competition here
CONMED Corporation (NYSE: CNMD)
AHCO vs CNMD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while CNMD trades at $49.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas CNMD's P/E ratio is 10.84. In terms of profitability, AHCO's ROE is -0.15%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, AHCO is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check CNMD's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
AHCO vs ATEC Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while ATEC trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas ATEC's P/E ratio is -157.50. In terms of profitability, AHCO's ROE is -0.15%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, AHCO is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check ATEC's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
AHCO vs TNDM Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, TNDM has a market cap of 1.4B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while TNDM trades at $19.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas TNDM's P/E ratio is -21.40. In terms of profitability, AHCO's ROE is -0.15%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, AHCO is more volatile compared to TNDM. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check TNDM's competition here
Heska Corporation (NASDAQ: HSKA)
AHCO vs HSKA Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas HSKA's P/E ratio is -62.49. In terms of profitability, AHCO's ROE is -0.15%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, AHCO is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
AHCO vs IART Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while IART trades at $16.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas IART's P/E ratio is 7.08. In terms of profitability, AHCO's ROE is -0.15%, compared to IART's ROE of -0.01%. Regarding short-term risk, AHCO is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check IART's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
AHCO vs PRCT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, PRCT has a market cap of 1.3B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while PRCT trades at $22.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas PRCT's P/E ratio is -11.73. In terms of profitability, AHCO's ROE is -0.15%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, AHCO is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check PRCT's competition here
Artivion, Inc. (NYSE: AORT)
AHCO vs AORT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, AORT has a market cap of 1.2B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while AORT trades at $25.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas AORT's P/E ratio is 42.63. In terms of profitability, AHCO's ROE is -0.15%, compared to AORT's ROE of -0.01%. Regarding short-term risk, AHCO is more volatile compared to AORT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check AORT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
AHCO vs AVNS Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas AVNS's P/E ratio is 27.77. In terms of profitability, AHCO's ROE is -0.15%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, AHCO is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check AVNS's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
AHCO vs LMRI Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, LMRI has a market cap of 1.2B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while LMRI trades at $12.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas LMRI's P/E ratio is -23.70. In terms of profitability, AHCO's ROE is -0.15%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, AHCO is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check LMRI's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
AHCO vs SILK Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas SILK's P/E ratio is -18.96. In terms of profitability, AHCO's ROE is -0.15%, compared to SILK's ROE of -0.35%. Regarding short-term risk, AHCO is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
AHCO vs IRMD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while IRMD trades at $83.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas IRMD's P/E ratio is 43.51. In terms of profitability, AHCO's ROE is -0.15%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, AHCO is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
AHCO vs FNA Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas FNA's P/E ratio is -19.83. In terms of profitability, AHCO's ROE is -0.15%, compared to FNA's ROE of -0.35%. Regarding short-term risk, AHCO is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check FNA's competition here
Enovis Corporation (NYSE: ENOV)
AHCO vs ENOV Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while ENOV trades at $18.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas ENOV's P/E ratio is 5.31. In terms of profitability, AHCO's ROE is -0.15%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, AHCO is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ENOV's competition here
Bioventus Inc. (NASDAQ: BVS)
AHCO vs BVS Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, BVS has a market cap of 953.2M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while BVS trades at $14.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas BVS's P/E ratio is 18.51. In terms of profitability, AHCO's ROE is -0.15%, compared to BVS's ROE of +0.28%. Regarding short-term risk, AHCO is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
AHCO vs CBLL Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, CBLL has a market cap of 937.9M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while CBLL trades at $24.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas CBLL's P/E ratio is -14.05. In terms of profitability, AHCO's ROE is -0.15%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, AHCO is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check CBLL's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
AHCO vs AVR Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, AVR has a market cap of 879M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while AVR trades at $9.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas AVR's P/E ratio is -4.66. In terms of profitability, AHCO's ROE is -0.15%, compared to AVR's ROE of -0.78%. Regarding short-term risk, AHCO is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check AVR's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
AHCO vs BBNX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, BBNX has a market cap of 873.7M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while BBNX trades at $19.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas BBNX's P/E ratio is -11.77. In terms of profitability, AHCO's ROE is -0.15%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, AHCO is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check BBNX's competition here
InMode Ltd. (NASDAQ: INMD)
AHCO vs INMD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, INMD has a market cap of 857M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while INMD trades at $14.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas INMD's P/E ratio is 10.35. In terms of profitability, AHCO's ROE is -0.15%, compared to INMD's ROE of +0.12%. Regarding short-term risk, AHCO is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check INMD's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
AHCO vs CSII Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas CSII's P/E ratio is -20.83. In terms of profitability, AHCO's ROE is -0.15%, compared to CSII's ROE of -0.14%. Regarding short-term risk, AHCO is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
AHCO vs SIBN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, SIBN has a market cap of 820.5M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while SIBN trades at $18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas SIBN's P/E ratio is -54.41. In terms of profitability, AHCO's ROE is -0.15%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, AHCO is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SIBN's competition here
Varex Imaging Corporation (NASDAQ: VREX)
AHCO vs VREX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, VREX has a market cap of 779.3M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while VREX trades at $18.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas VREX's P/E ratio is 19.48. In terms of profitability, AHCO's ROE is -0.15%, compared to VREX's ROE of +0.05%. Regarding short-term risk, AHCO is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check VREX's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
AHCO vs SSII Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, SSII has a market cap of 682.4M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while SSII trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas SSII's P/E ratio is -66.51. In terms of profitability, AHCO's ROE is -0.15%, compared to SSII's ROE of -0.27%. Regarding short-term risk, AHCO is more volatile compared to SSII. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SSII's competition here
Surmodics, Inc. (NASDAQ: SRDX)
AHCO vs SRDX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas SRDX's P/E ratio is -34.66. In terms of profitability, AHCO's ROE is -0.15%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, AHCO is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SRDX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
AHCO vs CTKB Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, CTKB has a market cap of 607M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while CTKB trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas CTKB's P/E ratio is -24.90. In terms of profitability, AHCO's ROE is -0.15%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, AHCO is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check CTKB's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
AHCO vs APEN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas APEN's P/E ratio is -9.43. In terms of profitability, AHCO's ROE is -0.15%, compared to APEN's ROE of -0.85%. Regarding short-term risk, AHCO is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check APEN's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
AHCO vs KIDS Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, KIDS has a market cap of 575.6M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while KIDS trades at $22.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas KIDS's P/E ratio is -18.99. In terms of profitability, AHCO's ROE is -0.15%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, AHCO is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check KIDS's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
AHCO vs DCTH Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, DCTH has a market cap of 568.9M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while DCTH trades at $16.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas DCTH's P/E ratio is 1648.00. In terms of profitability, AHCO's ROE is -0.15%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, AHCO is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
AHCO vs ZIMV Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, AHCO's ROE is -0.15%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, AHCO is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
AHCO vs CERS Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, CERS has a market cap of 521.9M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while CERS trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas CERS's P/E ratio is -51.70. In terms of profitability, AHCO's ROE is -0.15%, compared to CERS's ROE of -0.10%. Regarding short-term risk, AHCO is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
AHCO vs NPCE Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, NPCE has a market cap of 508M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while NPCE trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas NPCE's P/E ratio is -26.14. In terms of profitability, AHCO's ROE is -0.15%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, AHCO is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check NPCE's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
AHCO vs TCMD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, TCMD has a market cap of 493.3M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while TCMD trades at $21.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas TCMD's P/E ratio is 20.25. In terms of profitability, AHCO's ROE is -0.15%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, AHCO is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check TCMD's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
AHCO vs SGHT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, SGHT has a market cap of 454.3M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while SGHT trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas SGHT's P/E ratio is -14.91. In terms of profitability, AHCO's ROE is -0.15%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, AHCO is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SGHT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
AHCO vs CARL Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, CARL has a market cap of 424.1M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while CARL trades at $15.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas CARL's P/E ratio is -10.91. In terms of profitability, AHCO's ROE is -0.15%, compared to CARL's ROE of -0.38%. Regarding short-term risk, AHCO is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
AHCO vs PACB Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, PACB has a market cap of 419.3M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while PACB trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas PACB's P/E ratio is -3.29. In terms of profitability, AHCO's ROE is -0.15%, compared to PACB's ROE of -49.62%. Regarding short-term risk, AHCO is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check PACB's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
AHCO vs CLPT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, CLPT has a market cap of 418.7M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while CLPT trades at $13.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas CLPT's P/E ratio is -11.83. In terms of profitability, AHCO's ROE is -0.15%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, AHCO is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check CLPT's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
AHCO vs SENS Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, SENS has a market cap of 402.5M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while SENS trades at $9.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas SENS's P/E ratio is -4.32. In terms of profitability, AHCO's ROE is -0.15%, compared to SENS's ROE of -1.66%. Regarding short-term risk, AHCO is more volatile compared to SENS. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SENS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
AHCO vs OFIX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, OFIX has a market cap of 375.5M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while OFIX trades at $9.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas OFIX's P/E ratio is -6.05. In terms of profitability, AHCO's ROE is -0.15%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, AHCO is more volatile compared to OFIX. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check OFIX's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
AHCO vs CATX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, CATX has a market cap of 358.1M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while CATX trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas CATX's P/E ratio is -2.36. In terms of profitability, AHCO's ROE is -0.15%, compared to CATX's ROE of -0.42%. Regarding short-term risk, AHCO is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check CATX's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
AHCO vs TMCI Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, TMCI has a market cap of 312M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while TMCI trades at $4.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas TMCI's P/E ratio is -5.12. In terms of profitability, AHCO's ROE is -0.15%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, AHCO is more volatile compared to TMCI. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check TMCI's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
AHCO vs SMLR Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas SMLR's P/E ratio is 3.92. In terms of profitability, AHCO's ROE is -0.15%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, AHCO is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check SMLR's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
AHCO vs TLSI Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, TLSI has a market cap of 307.9M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while TLSI trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas TLSI's P/E ratio is -2.98. In terms of profitability, AHCO's ROE is -0.15%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, AHCO is more volatile compared to TLSI. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check TLSI's competition here
CapsoVision, Inc. (NASDAQ: CV)
AHCO vs CV Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, CV has a market cap of 299.3M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while CV trades at $5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas CV's P/E ratio is -2.40. In terms of profitability, AHCO's ROE is -0.15%, compared to CV's ROE of -1.78%. Regarding short-term risk, AHCO is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check CV's competition here
Avita Medical Inc. (NASDAQ: RCEL)
AHCO vs RCEL Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, RCEL has a market cap of 278.2M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while RCEL trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas RCEL's P/E ratio is -7.78. In terms of profitability, AHCO's ROE is -0.15%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, AHCO is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check RCEL's competition here
RxSight, Inc. (NASDAQ: RXST)
AHCO vs RXST Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, RXST has a market cap of 263.9M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while RXST trades at $6.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas RXST's P/E ratio is -5.64. In terms of profitability, AHCO's ROE is -0.15%, compared to RXST's ROE of -0.17%. Regarding short-term risk, AHCO is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check RXST's competition here
Profound Medical Corp. (NASDAQ: PROF)
AHCO vs PROF Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, PROF has a market cap of 250.4M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while PROF trades at $6.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas PROF's P/E ratio is -7.03. In terms of profitability, AHCO's ROE is -0.15%, compared to PROF's ROE of -0.56%. Regarding short-term risk, AHCO is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check PROF's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
AHCO vs INFU Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, INFU has a market cap of 246M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while INFU trades at $12.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas INFU's P/E ratio is 29.73. In terms of profitability, AHCO's ROE is -0.15%, compared to INFU's ROE of +0.15%. Regarding short-term risk, AHCO is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
AHCO vs MGRM Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas MGRM's P/E ratio is -12.00. In terms of profitability, AHCO's ROE is -0.15%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, AHCO is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
AHCO vs ELMD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, ELMD has a market cap of 232.1M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while ELMD trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas ELMD's P/E ratio is 21.40. In terms of profitability, AHCO's ROE is -0.15%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, AHCO is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
AHCO vs NVRO Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas NVRO's P/E ratio is -1.91. In terms of profitability, AHCO's ROE is -0.15%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, AHCO is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check NVRO's competition here
Neuronetics, Inc. (NASDAQ: STIM)
AHCO vs STIM Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, STIM has a market cap of 200.4M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while STIM trades at $2.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas STIM's P/E ratio is -6.55. In terms of profitability, AHCO's ROE is -0.15%, compared to STIM's ROE of -1.51%. Regarding short-term risk, AHCO is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check STIM's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
AHCO vs BSGM Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas BSGM's P/E ratio is -5.81. In terms of profitability, AHCO's ROE is -0.15%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, AHCO is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check BSGM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
AHCO vs LUCD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, LUCD has a market cap of 179.2M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while LUCD trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas LUCD's P/E ratio is -2.54. In terms of profitability, AHCO's ROE is -0.15%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, AHCO is more volatile compared to LUCD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
AHCO vs MDGS Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas MDGS's P/E ratio is -0.27. In terms of profitability, AHCO's ROE is -0.15%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, AHCO is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
AHCO vs QIPT Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas QIPT's P/E ratio is -15.87. In terms of profitability, AHCO's ROE is -0.15%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, AHCO is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check QIPT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
AHCO vs FOCL Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, FOCL has a market cap of 155.6M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while FOCL trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas FOCL's P/E ratio is -4.01. In terms of profitability, AHCO's ROE is -0.15%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, AHCO is more volatile compared to FOCL. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check FOCL's competition here
Quantum-Si incorporated (NASDAQ: QSI)
AHCO vs QSI Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, QSI has a market cap of 151.5M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while QSI trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas QSI's P/E ratio is -1.67. In terms of profitability, AHCO's ROE is -0.15%, compared to QSI's ROE of -0.47%. Regarding short-term risk, AHCO is more volatile compared to QSI. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check QSI's competition here
Inogen, Inc. (NASDAQ: INGN)
AHCO vs INGN Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, INGN has a market cap of 146.7M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while INGN trades at $5.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas INGN's P/E ratio is -5.96. In terms of profitability, AHCO's ROE is -0.15%, compared to INGN's ROE of -0.13%. Regarding short-term risk, AHCO is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
AHCO vs QTRX Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, QTRX has a market cap of 126.7M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while QTRX trades at $2.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas QTRX's P/E ratio is -1.06. In terms of profitability, AHCO's ROE is -0.15%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, AHCO is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check QTRX's competition here
iCAD, Inc. (NASDAQ: ICAD)
AHCO vs ICAD Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas ICAD's P/E ratio is -20.37. In terms of profitability, AHCO's ROE is -0.15%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, AHCO is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for AHCO.Check ICAD's competition here
LENSAR Inc (NASDAQ: LNSR)
AHCO vs LNSR Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, LNSR has a market cap of 105.4M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while LNSR trades at $8.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas LNSR's P/E ratio is 8.76. In terms of profitability, AHCO's ROE is -0.15%, compared to LNSR's ROE of +103.80%. Regarding short-term risk, AHCO is less volatile compared to LNSR. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check LNSR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
AHCO vs HJLI Comparison September 2026
AdaptHealth Corp. (NASDAQ: AHCO) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AHCO stands at 883M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, AHCO is priced at $6.49 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AHCO currently has a P/E ratio of 13.24, whereas HJLI's P/E ratio is N/A. In terms of profitability, AHCO's ROE is -0.15%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, AHCO is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for AHCO.Check HJLI's competition here